Investors purchased shares of CVS Health Corporation (NYSE:CVS) on weakness during trading hours on Friday. $111.51 million flowed into the stock on the tick-up and $45.60 million flowed out of the stock on the tick-down, for a money net flow of $65.91 million into the stock. Of all equities tracked, CVS Health Corporation had the 22nd highest net in-flow for the day. CVS Health Corporation traded down ($0.37) for the day and closed at $97.09

A number of analysts have recently weighed in on CVS shares. Credit Suisse Group AG reaffirmed a “buy” rating and issued a $115.00 price target on shares of CVS Health Corporation in a research note on Sunday, June 5th. Zacks Investment Research lowered shares of CVS Health Corporation from a “hold” rating to a “sell” rating in a research note on Monday, April 18th. Vetr raised shares of CVS Health Corporation from a “hold” rating to a “buy” rating and set a $113.29 price target for the company in a research note on Monday, April 4th. Jefferies Group reaffirmed a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 4th. Finally, Morgan Stanley reaffirmed a “buy” rating on shares of CVS Health Corporation in a research note on Thursday, April 7th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $113.72.

The company has a market capitalization of $104.28 billion and a PE ratio of 21.10. The firm’s 50 day moving average price is $95.72 and its 200 day moving average price is $98.33.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Tuesday, May 3rd. The pharmacy operator reported $1.18 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.16 by $0.02. The company earned $43.20 billion during the quarter, compared to the consensus estimate of $43.01 billion. During the same period in the previous year, the firm posted $1.14 EPS. The business’s quarterly revenue was up 18.9% compared to the same quarter last year. On average, analysts predict that CVS Health Corporation will post $5.83 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, August 1st. Shareholders of record on Thursday, July 21st will be paid a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date is Tuesday, July 19th.

In other CVS Health Corporation news, EVP Troyen A. Brennan sold 7,517 shares of CVS Health Corporation stock in a transaction that occurred on Thursday, May 5th. The shares were sold at an average price of $105.00, for a total value of $789,285.00. Following the transaction, the executive vice president now owns 69,601 shares of the company’s stock, valued at $7,308,105. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Larry J. Merlo sold 38,247 shares of CVS Health Corporation stock in a transaction that occurred on Thursday, May 5th. The shares were sold at an average price of $105.00, for a total transaction of $4,015,935.00. Following the completion of the transaction, the chief executive officer now directly owns 280,381 shares in the company, valued at approximately $29,440,005. The disclosure for this sale can be found here.

Several hedge funds have bought and sold shares of the stock. Vanguard Group Inc. increased its stake in CVS Health Corporation by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 68,950,833 shares of the pharmacy operator’s stock worth $6,741,323,000 after buying an additional 1,086,137 shares during the period. Morgan Stanley increased its stake in CVS Health Corporation by 12.8% in the fourth quarter. Morgan Stanley now owns 11,485,756 shares of the pharmacy operator’s stock worth $1,122,961,000 after buying an additional 1,304,751 shares during the period. Wells Fargo & Company MN increased its stake in CVS Health Corporation by 3.1% in the fourth quarter. Wells Fargo & Company MN now owns 10,271,213 shares of the pharmacy operator’s stock worth $1,004,217,000 after buying an additional 313,389 shares during the period. Dimensional Fund Advisors LP increased its stake in CVS Health Corporation by 8.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 8,937,908 shares of the pharmacy operator’s stock worth $873,912,000 after buying an additional 689,609 shares during the period. Finally, Bank of Montreal Can increased its stake in CVS Health Corporation by 0.4% in the fourth quarter. Bank of Montreal Can now owns 4,967,220 shares of the pharmacy operator’s stock worth $485,648,000 after buying an additional 19,949 shares during the period.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.